» Articles » PMID: 34218496

Income Gradient of Pharmaceutical Panic Buying at the Outbreak of the COVID-19 Pandemic

Overview
Journal Health Econ
Publisher Wiley
Date 2021 Jul 4
PMID 34218496
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We analyze the timing, magnitude, and income dependence of pharmaceutical panic buying around the outbreak of the COVID-19 pandemic in Hungary. We use district-level monthly and daily administrative data on detailed categories of pharmaceutical purchases, merge them to income statistics, and estimate multilevel panel models. Our main results are as follows. First, the days of therapy (DOT) of pharmaceutical purchases increased by more than 30% in March 2020, when major lockdown measures were announced. This pattern holds for almost all categories of pharmaceuticals. Second, shortly after the panic reactions, the aggregate amount of pharmaceutical purchases returned to their preshock levels; however, the frequency of pharmacy visits decreased. Third, the panic buying reaction was significantly stronger in richer geographical areas, where-according to the daily data-people also reacted earlier to the pandemic-related news. Overall, the results suggest that panic buying of pharmaceuticals can have detrimental effects on vulnerable populations.

Citing Articles

Household Pharmaceutical Waste Disposal as a Global Problem-A Review.

Rogowska J, Zimmermann A Int J Environ Res Public Health. 2022; 19(23).

PMID: 36497873 PMC: 9737308. DOI: 10.3390/ijerph192315798.


The impact of paid social Q&A on panic buying and digital hoarding at the stage of coexistence with COVID-19: The moderating role of sensitivity to pain of payment.

Wang Y, Ding A, Xu C Int J Disaster Risk Reduct. 2022; 84:103472.

PMID: 36465701 PMC: 9708103. DOI: 10.1016/j.ijdrr.2022.103472.


Psychotropic drug purchases during the COVID-19 pandemic in Italy and their relationship with mobility restrictions.

Marazzi F, Piano Mortari A, Belotti F, Carra G, Cattuto C, Kopinska J Sci Rep. 2022; 12(1):19336.

PMID: 36369240 PMC: 9651906. DOI: 10.1038/s41598-022-22085-4.


Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.

Di Novi C, Leporatti L, Levaggi R, Montefiori M J Econ Behav Organ. 2022; 204:1-14.

PMID: 36268162 PMC: 9562624. DOI: 10.1016/j.jebo.2022.10.012.


Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models.

Elek P, Csanadi M, Fadgyas-Freyler P, Gervai N, Oross-Becsi R, Szecsenyi-Nagy B BMJ Open. 2022; 12(8):e061941.

PMID: 35981776 PMC: 9393855. DOI: 10.1136/bmjopen-2022-061941.


References
1.
Biro A, Hajdu T, Kertesi G, Prinz D . Life expectancy inequalities in Hungary over 25 years: The role of avoidable deaths. Popul Stud (Camb). 2021; 75(3):443-455. DOI: 10.1080/00324728.2021.1877332. View

2.
Clement J, Jacobi M, Greenwood B . Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. PLoS One. 2021; 16(4):e0249453. PMC: 8016279. DOI: 10.1371/journal.pone.0249453. View

3.
Chatterji P, Li Y . Effects of the COVID-19 Pandemic on Outpatient Providers in the United States. Med Care. 2020; 59(1):58-61. DOI: 10.1097/MLR.0000000000001448. View

4.
Chetty R, Friedman J, Stepner M . THE ECONOMIC IMPACTS OF COVID-19: EVIDENCE FROM A NEW PUBLIC DATABASE BUILT USING PRIVATE SECTOR DATA. Q J Econ. 2024; 139(2):829-889. PMC: 11189622. DOI: 10.1093/qje/qjad048. View

5.
Gaal P, Szigeti S, Csere M, Gaskins M, Panteli D . Hungary health system review. Health Syst Transit. 2012; 13(5):1-266. View